Clinical Trials Directory

Trials / Completed

CompletedNCT04672382

Evaluation of Peripheral Itch Mechanisms Following Injection of Morphine

Effect of Intradermal Morphine Application on Histaminergic and Non-histaminergic Itch and Related TRPV1 and Antihistamine Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Aalborg University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to the effect of opioid (morphine) intradermal application on histaminergic and non-histaminergic itch. In particular, we would like to demonstrate that also peripheral administration of morphine may affect mast cell release of histamine.

Detailed description

Opioids (i.e. substances extracted from opium poppies, e.g. morphine) are used for treatment of both acute and chronic pain conditions as well as in surgical procedures. Opioids render effective pain relief, however, they may cause bothersome itch as a side effect. With this series of experiments, we wish to clarify how an injection with morphine in the skin layer called dermis (located right below the upper skin) will affect itch.

Conditions

Interventions

TypeNameDescription
DRUGMorphineDuring the 1st session, each of the middle forearms of the subject will be divided into two squared areas (4x4 cm) located 3 cm apart. Two areas will be treated with an intradermal injection of morphine (0.05 ml, 0.1 mg/ml), and two areas with an intradermal injection of isotonic saline.

Timeline

Start date
2021-07-01
Primary completion
2022-05-31
Completion
2022-12-31
First posted
2020-12-17
Last updated
2023-01-18

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04672382. Inclusion in this directory is not an endorsement.